1. Oxidative Stress and Liver Cancer: Etiology and Therapeutic Targets
   Zhanpeng Wang et al, 2016, Oxidative Medicine and Cellular Longevity CrossRef
2. Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
   Man Yao et al, 2023, Frontiers in Pharmacology CrossRef
3. Variant biomarker discovery using mass spectrometry-based proteogenomics
   Luke Reilly et al, 2023, Frontiers in Aging CrossRef
4. Prognostic efficacy and prognostic factors of TACE plus TKI with ICIs for the treatment of unresectable hepatocellular carcinoma: A retrospective study
   Ziqiang Han et al, 2022, Frontiers in Oncology CrossRef
5. Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway
   Sun Guangshun et al, 2022, Journal of Oncology CrossRef
6. Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytesin vivoandin vitro
   Wen-Chao Wang et al, 2019, Cancer Biology & Therapy CrossRef
7. Immunological Basis of Genesis of Hepatocellular Carcinoma: Unique Challenges and Potential Opportunities through Immunomodulation
   Kumar Jayant et al, 2020, Vaccines CrossRef
8. Immune gene signature delineates a subclass of thyroid cancer with unfavorable clinical outcomes
   Jingtai Zhi et al, 2020, Aging CrossRef
9. Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
   Ester García-Pras et al, 2021, Cancers CrossRef
10. A prognostic signature established based on genes related to tumor microenvironment for patients with hepatocellular carcinoma
    Zhongfeng Cui et al, 2024, Aging CrossRef
11. Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma — a Review
    Irmak Ayvaz et al, 2021, Journal of Gastrointestinal Cancer CrossRef
12. A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors
    Toshihiko Doi et al, 2019, Investigational New Drugs CrossRef
13. Bioinformatics profiling identifies seven immune-related risk signatures for hepatocellular carcinoma
    Feng Xue et al, 2020, PeerJ CrossRef
14. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review
    Yongjie Huang et al, 2022, International Journal of Nanomedicine CrossRef
15. The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages
    Daria Capece et al, 2013, BioMed Research International CrossRef
16. Integrated Analysis Reveals Critical Ferroptosis Regulators and FTL Contribute to Cancer Progression in Hepatocellular Carcinoma
    Shaoying Ke et al, 2022, Frontiers in Genetics CrossRef
17. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma
    Peng-Zhan Deng et al, 2022, World Journal of Gastroenterology CrossRef
18. Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review)
    Dongdong Xue et al, 2021, Cancer Biology & Therapy CrossRef
19. Sorting Out Pandora’s Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma
    Jennifer Altomonte et al, 2014, Frontiers in Oncology CrossRef
20. Prognostic Value of Gamma-Glutamyl Transpeptidase to Lymphocyte Count Ratio in Patients With Single Tumor Size ≤ 5 cm Hepatocellular Carcinoma After Radical Resection
    Minjun Liao et al, 2019, Frontiers in Oncology CrossRef
21. Angiogenic inhibitors delivered by the type III secretion system of tumor-targeting Salmonella typhimurium safely shrink tumors in mice
    Lei Shi et al, 2016, AMB Express CrossRef
22. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
    Jinsen Zhang et al, 2020, Journal of Molecular Neuroscience CrossRef
23. Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors
    Gustavo Rodrigues Martins et al, 2016, Mediators of Inflammation CrossRef
24. The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer
    Fabio Gionfra et al, 2019, Frontiers in Endocrinology CrossRef
25. Chemokine ligand 20 enhances progression of hepatocellular carcinomaviaepithelial-mesenchymal transition
    Ke-Zhu Hou, 2015, World Journal of Gastroenterology CrossRef
26. Apatinib Inhibits the Invasion and Metastasis of Liver Cancer Cells by Downregulating MMP-Related Proteins via Regulation of the NF-κB Signaling Pathway
    Xiaoxiao He et al, 2020, BioMed Research International CrossRef